✦ LIBER ✦

Phase 1, randomized, double-blind, placebo-controlled, multiple intravenous, dose-ascending study of sirukumab in cutaneous or systemic lupus erythematosus

✍ Scribed by Szepietowski, Jacek C.; Nilganuwong, Surasak; Wozniacka, Anna; Kuhn, Annegret; Nyberg, Filippa; van Vollenhoven, Ronald F.; Bengtsson, Anders A.; Reich, Adam; de Vries, Dick E.; van Hartingsveldt, Bart; Robinson, Don; Gordon, Robert; Hsu, Benjamin

Book ID: 121650597
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 259 KB
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.38091

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II, randomized, double-blind, pl

A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus

✍ Wallace, Daniel J. ;Stohl, William ;Furie, Richard A. ;Lisse, Jeffrey R. ;McKay, 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 372 KB 👁 2 views

## Abstract ## Objective To assess the safety, tolerability, biologic activity, and efficacy of belimumab in combination with standard of care therapy (SOC) in patients with active systemic lupus erythematosus (SLE). ## Methods Patients with a Safety of Estrogens in Lupus Erythematosus: National

Effect of long-term belimumab treatment

Effect of long-term belimumab treatment on b cells in systemic lupus erythematosus: Extension of a phase II, double-blind, placebo-controlled, dose-ranging study

✍ Annett M. Jacobi; Weiqing Huang; Tao Wang; William Freimuth; Inaki Sanz; Richard 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 593 KB

EFFECTS OF AMG 145, A FULLY HUMAN MONOCL

EFFECTS OF AMG 145, A FULLY HUMAN MONOCLONAL ANTIBODY AGAINST PCSK9, ON LOW-DENSITY LIPOPROTEIN CHOLESTEROL IN SUBJECTS TAKING STATINS: A PHASE 1, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, ASCENDING MULTIPLE-DOSE STUDY

✍ Dias, Clapton; Shaywitz, Adam; Cooke, Blaire; Uy, Stephen; Emery, Maurice; Gibbs 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Pharmacokinetics, tolerability, and prel

Pharmacokinetics, tolerability, and preliminary efficacy of paquinimod (ABR-215757), a new quinoline-3-carboxamide derivative: Studies in lupus-prone mice and a multicenter, randomized, double-blind, placebo-controlled, repeat-dose, dose-ranging study in patients with systemic lupus erythematosus

✍ Anders A. Bengtsson; Gunnar Sturfelt; Christian Lood; Lars Rönnblom; Ronald F. v 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB

309 A RANDOMIZED, DOUBLE-BLIND, PLACEBO-

309 A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF rhFGF18 ADMINISTERED INTRAARTICULARLY USING SINGLE OR MULTIPLE ASCENDING DOSES IN PATIENTS WITH PRIMARY KNEE OSTEOARTHRITIS (OA), SCHEDULED FOR TOTAL KNEE REPLACEMENT

✍ L.E. Dahlberg; K. Flechsenhar; D. Dreher; S. Goûteux; J.S. Jurvelin 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

65 A RANDOMIZED, DOUBLE-BLIND, PLACEBO-C

65 A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF RHFGF18 ADMINISTERED INTRAARTICULARLY USING SINGLE OR MULTIPLE ASCENDING DOSES IN PATIENTS WFTH PRIMARY KNEE OSTEOARTHRITIS (OA), NOT EXPECTED TO REQUIRE KNEE SURGERY WITHIN 1 YEAR

✍ R. McPherson; K. Flechsenhar; S. Hellot; F. Eckstein 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 141 KB